Category: Joint Purification Systems

Joint Purification Systems, Inc. Announces $7.8 Million Series A Financing

Joint Purification Systems Inc. announced today that it has closed a $7.8 million Series A financing.

SOLANA BEACH, CALIF. (PRWEB) APRIL 18, 2018

Joint Purification Systems Inc. (JPS), an early stage medical device company developing novel combination products to treat chronic peri-prosthetic joint infection (PJI), announced today that it has closed a $7.8 million Series A financing. The financing was led by Johnson & Johnson Innovation – JJDC, Inc. MedVest Fund II was also a new investor in the round. Proceeds will be used for preparation of the company’s first products in the X7 Spacer System for initiation of human clinical studies.

Continue Reading

Scroll to top